Crism Therapeutics (STU:A7L) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:A7L Crism Therapeutics Corp STU:A7L
37 GF Score
Price €2.24
! 3 Warning Signs
View Full Analysis

What is Crism Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


STU:A7L vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Crism Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Crism Therapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Crism Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Crism Therapeutics's Short Interest falls into.


STU:A7L
37GF Score
Crism Therapeutics Corp STU:A7L
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crism Therapeutics Business Description

Other Exchanges CRTX:UK
Address Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB
Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.
37GF Score

Get the complete analysis for STU:A7L

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.24
Price